The Prevalence of Iron Deficiency and the Effectiveness of Ferinject® in Patients With HFpEF (ID-HFpEF)

PHASE4RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 28, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Chronic Heart FailureIron Deficiency, Latent
Interventions
DRUG

Ferinject

The calculation of the dose of iron carboxymaltosate (Ferinject ® preparation) for the purpose of correction of iron will be carried out on the basis of the following step-by-step approach: determination of individual iron needs, calculation and administration of iron dose, assessment of the saturation of the patient's body with iron 6 weeks after infusion.

OTHER

Diet therapy

Patients will receive diet therapy to correct latent iron deficiency

Trial Locations (1)

634012

RECRUITING

Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk

All Listed Sponsors
lead

Tomsk National Research Medical Center of the Russian Academy of Sciences

OTHER